Research and Markets: Shigella Infections (Shigellosis) Pipeline Insights Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/52w4v4/shigella) has announced the addition of the "Shigella Infections (Shigellosis)-Pipeline Insights" subscription to their offering.

This Shigella Infections (Shigellosis)-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Shigella Infections (Shigellosis).

This report provides information on the therapeutic development based on the Shigella Infections (Shigellosis) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Shigella Infections (Shigellosis) Overview
  2. Shigella Infections (Shigellosis) Pipeline Therapeutics
  3. Shigella Infections (Shigellosis) Therapeutics under Development by Companies
  4. Shigella Infections (Shigellosis) Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Shigella Infections (Shigellosis) Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Shigella Infections (Shigellosis) Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Shigella Infections (Shigellosis) Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Shigella Infections (Shigellosis) - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Shigella Infections (Shigellosis) - Discontinued Products
  19. Shigella Infections (Shigellosis) - Dormant Products
  20. Companies Involved in Therapeutics Development for Shigella Infections (Shigellosis)
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/52w4v4/shigella

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals